Goldman Sachss China dealmaker stops tapping US investors - Financial Times
| 4743 Stock | TWD 107.00 5.50 5.42% |
Slightly above 55% of Oneness Biotech's sophisticated investors are presently thinking to get in. The analysis of current outlook of investing in Oneness Biotech Co suggests that some traders are interested regarding Oneness Biotech's prospects. Oneness Biotech's investing sentiment can be driven by a variety of factors including economic data, Oneness Biotech's earnings reports, geopolitical events, and overall market trends.
Oneness Biotech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Oneness daily returns and investor perception about the current price of Oneness Biotech Co as well as its diversification or hedging effects on your existing portfolios.
Oneness |
Goldman Sachss China dealmaker stops tapping US investors Financial Times
Read at news.google.com
 |
Oneness Biotech Fundamental Analysis
We analyze Oneness Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oneness Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oneness Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Oneness Biotech is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Oneness Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oneness Biotech stock to make a market-neutral strategy. Peer analysis of Oneness Biotech could also be used in its relative valuation, which is a method of valuing Oneness Biotech by comparing valuation metrics with similar companies.
Peers
Oneness Biotech Related Equities
| 3176 | Medigen Biotechnology | 2.64 | ||||
| 4174 | OBI Pharma | 2.42 | ||||
| 4128 | Microbio | 1.91 | ||||
| 6547 | Medigen Vaccine | 1.03 |
Additional Tools for Oneness Stock Analysis
When running Oneness Biotech's price analysis, check to measure Oneness Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oneness Biotech is operating at the current time. Most of Oneness Biotech's value examination focuses on studying past and present price action to predict the probability of Oneness Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oneness Biotech's price. Additionally, you may evaluate how the addition of Oneness Biotech to your portfolios can decrease your overall portfolio volatility.